PT  - JOURNAL ARTICLE
AU  - Rishi Khusial
AU  - Persijn Honkoop
AU  - Omar Usmani
AU  - Marcia Soares
AU  - Martyn Biddiscombe
AU  - Sally Meah
AU  - Matteo Bonini
AU  - Antonios Lalas
AU  - Julia Koopmans
AU  - Jiska Snoeck-Stroband
AU  - Steffen Ortmann
AU  - Konstantinos Moustakas
AU  - Konstantinos Votis
AU  - Dimitrios Tzovaras
AU  - Kian Fan Chung
AU  - Stephen Fowler
AU  - Jacob Sont
TI  - myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial
AID  - 10.1183/13993003.congress-2019.PA745
DP  - 2019 Sep 28
TA  - European Respiratory Journal
PG  - PA745
VI  - 54
IP  - suppl 63
4099  - http://erj.ersjournals.com/content/54/suppl_63/PA745.short
4100  - http://erj.ersjournals.com/content/54/suppl_63/PA745.full
SO  - Eur Respir J2019 Sep 28; 54
AB  - Background: Mobile health (mHealth) could play an important role in assisting patients self-managing their asthma. Therefore we developed the myAirCoach mHealth system to aid self-management. We aimed to assess the effect of the myAirCoach system in addition to usual care on asthma control.Methods: In a randomized controlled trial in the Netherlands we included 30 patients with uncontrolled asthma using a staggered enrolment with 3-7 months follow-up. Patients received either ‘usual care’ or ‘usual care + self-management support via ‘myAirCoach’’. In addition, we performed a 3-month before-after study in 12 patients in the UK. Asthma control was measured with the Asthma Control Questionnaire (ACQ), with a minimal important difference (MID) of 0.5. Secondary outcomes were exacerbation rate and quality of life, measured by the mini Asthma Quality of Life Questionnaire (mAQLQ) with a MID of 0.5. The myAirCoach system consisted of an app, myAirCoach inhaler add-on, indoor air-quality monitor, physical activity tracker, home spirometer and FeNO device.Results: Asthma control improved in the Dutch intervention group compared to controls (ACQ-difference 0.70, p=0.006). A total of 4 severe exacerbations occurred in the intervention group compared to 12 in the control group (hazard ratio 0.22, 95%CI 0.07-0.71, p=0.011). Also quality of life improved significantly (mAQLQ difference 0.53, p= 0.04). In the UK patients, asthma control improved by 0.86 compared to baseline (p=0.007) and quality of life was 0.16 higher (p=0.64).Conclusion: The myAirCoach mHealth self-management system provides an improvement in asthma control and quality of life and a reduction in asthma exacerbation.FootnotesCite this article as: European Respiratory Journal 2019; 54: Suppl. 63, PA745.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).